These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced 99m Tc. Meléndez-Alafort L, Ferro-Flores G, De Nardo L, Bello M, Paiusco M, Negri A, Zorz A, Uzunov N, Esposito J, Rosato A. Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241 [Abstract] [Full Text] [Related]
4. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Goins B, Bao A, Phillips WT. Methods Mol Biol; 2017 Mar; 1522():155-178. PubMed ID: 27837538 [Abstract] [Full Text] [Related]
5. Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals. Koźmiński P, Gniazdowska E. Nucl Med Biol; 2015 Jan; 42(1):28-37. PubMed ID: 25218025 [Abstract] [Full Text] [Related]
6. Preparation of clinical-scale 99Mo/99mTc column generator using neutron activated low specific activity 99Mo and nanocrystalline γ-Al2O3 as column matrix. Chakravarty R, Ram R, Dash A, Pillai MR. Nucl Med Biol; 2012 Oct; 39(7):916-22. PubMed ID: 22632898 [Abstract] [Full Text] [Related]
10. Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands. Martini P, Pasquali M, Boschi A, Uccelli L, Giganti M, Duatti A. Molecules; 2018 Aug 15; 23(8):. PubMed ID: 30111708 [Abstract] [Full Text] [Related]
11. Radiolabeling of bionanomaterials with technetium 99m: current state and future prospects. Trusova V, Karnaukhov I, Zelinsky A, Borts B, Ushakov I, Sidenko L, Gorbenko G. Nanomedicine (Lond); 2024 Jul 14; 19(17):1569-1580. PubMed ID: 39011593 [Abstract] [Full Text] [Related]
12. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide. Maresca KP, Marquis JC, Hillier SM, Lu G, Femia FJ, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW. Bioconjug Chem; 2010 Jun 16; 21(6):1032-42. PubMed ID: 20402463 [Abstract] [Full Text] [Related]
13. Single amino acid chelates (SAAC): a strategy for the design of technetium and rhenium radiopharmaceuticals. Bartholomä M, Valliant J, Maresca KP, Babich J, Zubieta J. Chem Commun (Camb); 2009 Feb 07; (5):493-512. PubMed ID: 19283279 [Abstract] [Full Text] [Related]
14. Preparation and biodistribution in mice of a new radiopharmaceutical-technetium-99m labeled methotrexate, as a tumor diagnostic agent. Dar UK, Khan IU, Javed M, Ahmad F, Ali M, Hyder SW. Hell J Nucl Med; 2012 Feb 07; 15(2):120-4. PubMed ID: 22833858 [Abstract] [Full Text] [Related]
15. Melanoma targeting with [99mTc(N)(PNP3)]-labeled α-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties. Carta D, Salvarese N, Morellato N, Gao F, Sihver W, Pietzsch HJ, Biondi B, Ruzza P, Refosco F, Carpanese D, Rosato A, Bolzati C. Nucl Med Biol; 2016 Dec 07; 43(12):788-801. PubMed ID: 27694057 [Abstract] [Full Text] [Related]
16. [Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse]. Qi Y, Li G, Chi X, Du L, Huang K, Zhang H, Huang B. Zhongguo Fei Ai Za Zhi; 2015 Jul 07; 18(7):422-6. PubMed ID: 26182867 [Abstract] [Full Text] [Related]